Blue Owl Capital Holdings LP
Source: SEC Form 13F · as of Mar 2026Blue Owl Capital Holdings LP holds 16 biotech & pharma companies tracked by BioSniper, totaling $71.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$71.9M
| Company | Shares | Value |
|---|---|---|
| CMPXCompass Therapeutics, Inc. | 2,941,525 | $15.6M |
| CRVSCorvus Pharmaceuticals, Inc. | 545,000 | $8.0M |
| RAREUltragenyx Pharmaceutical Inc. | 302,638 | $6.3M |
| AQSTAquestive Therapeutics, Inc. | 1,347,932 | $5.6M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 61,455 | $5.3M |
| IMMXImmix Biopharma, Inc. | 547,552 | $5.0M |
| LENZLENZ Therapeutics, Inc. | 506,722 | $4.6M |
| KALVKalVista Pharmaceuticals, Inc. | 215,000 | $4.3M |
| OVIDOvid Therapeutics Inc. | 1,904,666 | $4.2M |
| PVLAPALVELLA THERAPEUTICS, INC. | 31,259 | $3.9M |
| ADCTADC Therapeutics SA | 733,568 | $2.6M |
| EVMNEvommune, Inc. | 100,000 | $2.3M |
| ORICOric Pharmaceuticals, Inc. | 150,000 | $1.9M |
| SGMTSagimet Biosciences Inc. | 333,877 | $1.7M |
| CAHCardinal Health Inc. | 1,718 | $363K |
| CAICaris Life Sciences Inc. | 4,711 | $84K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.